Table 1.
Frequency, No. (%)a | |
---|---|
Study classification | |
Nonshortage drug | 1,096 (72.2) |
Shortage drug | 421 (27.8) |
Dosage form | |
Oral only | 574 (37.8) |
IV only | 452 (29.8) |
Oral and IV | 291 (19.2) |
Other | 200 (13.2) |
Therapeutic class | |
Other | 676 (44.6) |
Cardiovascular | 227 (15.0) |
Antimicrobial | 207 (13.6) |
Antineoplastic | 160 (10.5) |
Analgesic | 109 (7.2) |
Electrolyte | 74 (4.9) |
Antipsychotic | 41 (2.7) |
Anesthetic | 23 (1.5) |
Controlled substance schedule | |
Schedule II | 78 (5.1) |
Schedules III–V | 53 (3.5) |
Orphan drug status | 250 (16.5) |
Branded/generic product availability | |
Both branded and generic | 675 (44.5) |
Generic only | 458 (30.2) |
Branded only | 384 (25.3) |
No. of manufacturers per drug, mean (SD) | 4.871 (4.641) |
Abbreviations: IV, intravenous; SD, standard deviation.
aUnless indicated otherwise.